Award reflects company's consistently high level of customer service

LF-ONE System Available as "Buy it Now" at www.growhyve.com

In celebration of Rapper Chef Seans new single release on July 30th, 2019 "No Name" through Sony/ The Orchard, a single release party will be held at The Pheonix in Beverly Hills, CA.

Fit Farm hosts individuals, groups, companies and fundraisers too … all are welcome. Now, with the nation's only permanent obstacle course with lodging, The Fit Farm Fury is a perfect turnkey solution for fundraising and corporate events.

Chino Valley Ranchers has released a stunningly beautiful new video to promote its pasture raised egg line of products.

"Professor J" has been blazing trails in applied computational chemistry for pharmaceutical and cosmetic color additive research since her Rowan University days, and has actively passed on her love of the profession by teaching the next generation.

Dr. Armstrong has been endorsed by Marquis Who's Who as a leader in the chemistry and academic industries

"It's A Dog's Life" Exhibit Runs Through September 30th

Receptra Naturals says "Happy National CBD Day" to the people and pets whose lives they work to impact

HealthEx misclassified its couriers as independent contractors and did not pay them an overtime premium when they worked overtime hours.

Laura Prince's new book detailing the death of her brother has been called "insightful", "powerful" "vivid" "absorbing" and "spellbinding".

ArmoryShop is already proving its craft with high-quality Star Wars costumes and armor. With their new website, they'll be able to cater to clients from all parts of the world.

Even before the release of the last movie in the series, ArmoryShop is ready to offer the Sith Trooper Armor to the avid fans.

The 9th episode of the Star Wars series is going to be released on the 19th of December and will introduce new antagonists called the Sith Troopers. ArmoryShop is ready to dispatch the initial orders of the costume along with the latest props.

Launching a special gift for Star Wars admirers, ArmoryShop offers the Splash helmet. It is a unique piece of art and perfectly suited for the lovers of the franchise.

Dedicated to improving the lives of low income and working class families, women of all races and all people of color, Ms. Davis was the recipient of Georgia Trend's 40 Under 40 Award in 2019

B.BéNI is a New England based inspirational jewelry company that offers men's necklaces and a wide selection of jewelry including bracelets, necklaces, sterling silver, earrings and Christian jewelry that will touch the heart.

ARMOR has just reached an important milestone in the production of its flexible organic photovoltaic film, ASCA©.

Deal brings Turfgrass with less "inputs" to major national home improvement stores

Prospect Hill Orchards is excited to announce their bicentennial celebration with fun activities for all ages--September 23 and 24 from 10am-4pm at Prospect Hill Orchards located at 73 Clark's Lane in Milton. Admission is free.

Farmers and vendors selling food at the farmers market, as well as consumers/shoppers, should understand the necessary steps to reducing the risk of illness from food.

The Farmers Arts Metairie Market, FAMM, is set to open its introductory 2018 season on Tuesday 5/15/2018 from 3:30-7:30pm.

Loaves and Fishes Farm partners with CourseVector to create website with donation portal, event listings

By Nina Culver For The Spokesman-Review

AUTOCROP system now re-branded as HYVE™ to be most descriptive of company's indoor farming products.

Taking Agriculture in Nigeria to the Next Level

Firm signed MoU with Felcra in October to set up business in Malaysia

New York attorney sends urgent letter to Governor Cuomo, praising the leader's handling of the crisis and urging financial support for healthcare workers, police officers, firefighters, and others who suffer injuries fighting the coronavirus.

Feature film in development by Celestial Cinema Productions shows the triumphs of Armenian Immigrants.

i.b.s.® as a first foreign security company now approved in Latvia and Lithuania (Baltics)

H.H. Dorje Chang Buddha III was Compelled and Could Not Decline

Festival on Saturday March 14, 2020, Features Raffles, Graffiti Art Contest, Arts and Crafts Vendors, Food Trucks and Snap and Share Art Walk

Rural America Could Be Devastated by Weakening the Farm Bill

Washington Wheat Calls For Bipartisan Action

Washington Wheat Speaks Out Against Farm Bill Critics

WAWG and WGC Calls for an Immediate Short Term Extension, Farmers Need Stability and Certainty

Company is positively disrupting the way the world grows and eats

Biopharma shares have outperformed the broader market year-to-date, giving rise to apprehension over whether a pullback is in the offing. An analyst at BofA Securities said Friday that now is the time to go from defensive to offensive in the sector, as quarantines are winding down in several parts of the globe.The Biopharma Analyst Analyst Geoff Meacham shortlisted Eli Lilly And Co (NYSE: LLY), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), Bristol-Myers Squibb Co (NYSE: BMY), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) and Amgen, Inc. (NASDAQ: AMGN) as biopharma stocks where he would put his money to work.The analyst has the following ratings and price targets for the shares: * Lilly: Buy/$165 * Vertex: Buy/$300 * Bristol-Myers Squibb: Buy/raised the price target from $75 to $80 * BioMarin: Buy/lifted price target from $110 to $120 * Amgen: Buy/price target increased from $265 to $2755 Reasons For BofA's Bullish Disposition BofA is increasingly bullish on the biopharma group due to the following factors, Meacham said: * Expectations for robust revenue growth of 6% in the second half of 2020 compared to the first-half, which is double that of the S&P 500's revenue growth. * Reasonable price-earnings for the stocks in the sector. * Many value-creating events lined up for the second half. * Lower policy risk stemming from goodwill earned from the COVID-19 pipeline. * A consistently positive FDA backdrop.Q1 Earnings Get 'A' Grade All of the big biotechs and major pharma companies reported both revenue and adjusted EPS beats in the first quarter, with Lilly and Vertex even raising some parts of their 2020 guidance, Meacham said.Citing slower new starts and forex headwinds, Bristol-Myers Squibb and BioMarin lowered their 2020 revenue guidance, but maintained their EPS guidance, the analyst said. Meacham expressed surprise at Merck & Co., Inc. (NYSE: MRK) and Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) lowering their 2020 revenue and adjusted EPS guidance, given his belief that oncology or orphan diseases wouldn't be as sensitive to COVID-19 disruption.See also: Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates Lilly One of The Higher Quality Stocks In BofA's Coverage Lilly is a source of differentiated growth given its early product cycle and diversified base business, including diabetes, immunology and immunotoxicology and migraine, and an advancing late-stage pipeline of potentially best-in-class or first-in-class therapies, Meacham said.The analyst said he likes Lily's potential for additional earnings growth in 2020-2021 and views Lilly as one of the higher quality stocks in his coverage despite its higher valuation. The prospects for 2021 look attractive, with selpercatinib potentially launching in non-small cell lung cancer and thyroid cancer by year's end, and tirzepatide approval in 2021 representing a "step change" for the diabetes franchise, he said. Consensus For Vertex To Move Higher? Vertex has a richer -- though well-deserved -- valuation, due to its differentiated growth profile, Meacham said.Given that Vertex's commercial execution is largely unaffected by the COVID-19 pandemic, the analyst said investors will begin to look forward to 2021 sooner than for other companies with more commercial risk.BofA expects consensus estimates to continue to move higher, making Vertex's valuation even more attractive.Bristol-Myers Has Highly Differentiated Growth With an estimated 8% revenue growth and 19% EPS growth in 2021 compared to 5-6% and 12%, respectively, for peers, and with six new launches expected this year, 2020 is shaping up to be a very robust period for Bristol-Myers despite the ongoing COVID-19 headwinds, Meacham said. The analyst said the company's growth looks highly differentiated.An increasingly diversified product mix and beatable launch expectations position the company for meaningful upside to consolidated P&L, with improving synergies, he said. BioMarin's 'Game-Changing' Late-Stage Pipeline BioMarin's late-stage pipeline in valrox and vosoritide have improved its growth outlook, Meacham said.The analyst termed the company's late-stage pipeline as "game-changing." The second-half launch of Roctavian is the most important catalyst for the company this year, with the product likely to accelerate the company's already above-average growth profile, he said. "We see BioMarin as one of the higher quality names in our coverage universe given its clean growth story and it remains our SMid cap top pick." Amgen Looks To New Product Growth To Compensate For Legacy Product Erosion The long-term outlook for Amgen's Otezla is improving given the recently announced Phase 3 data for mild-to-moderate psoriasis, Meacham said.The company rapidly refocused its story from legacy product erosion to new product growth with the acquisition of Otezla from the Bristol/Celgene deal, the analyst said. "Since then Amgen's growth profile has only improved, led by an expanded addressable market for Otezla, outperforming Amgen Biosimilars and Evenity franchises, aggressive formulary negotiation for Aimovig, and an exciting pipeline in AMG 510 and tezepelumab looking to contribute as soon as 2021." The Price Action The iShares NASDAQ Biotechnology Index (NASDAQ: IBB) was last seen trading up 1.25% to 128.76, adding to its 5.6% year-to-date gain. Related Link: The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace See more from Benzinga * The Daily Biotech Pulse: Ayala IPO, Pluristem Starts Phase 2 Trial Of COVID Treatment, European Nod For Takeda * The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500 * The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Illumitex's FarmVisionAI provides remote visualization, AI analysis, and labor management alleviating COVID-19 driven operational constraints

Also: Math for Programmers!; If #Programming languages had honest slogans #humor; 5 Papers on CNNs Every Data Scientist Should Read; Why Understanding CVEs Is Critical for Data Scientists

Climbing coconut and arecanut trees to harvest their prizes is strenuous, dangerous work, and requires a young body. But in Dakshina Kannada, India, "there is a substantial migration of well-educated youngsters to the cities for white collar jobs," K. Ganapathi Bhat told India's The News Minute. "There is a huge scarcity of employment in labour-intensive sectors like agriculture, especially those skilled in climbing trees."

"Having been born in a family with an agricultural background, it was painful to see the ripe coconut and arecanut either eaten by birds or falling across the fields," Bhat says. At 60 years of age, he's too old to climb the trees himself. But unlike most farmers, he has a Bachelors of Science in Physics, Chemistry and Maths. Thus he cobbled this together:

The bike-based contraption runs on gas, using what appears to be a chainsaw motor. After testing it out for two years on roughly 2,000 arecanut trees on his own farm, Bhat reckons the "mileage" is 90 trees per liter of gas (360 trees/gallon), and that the machine can carry an 80kg (175-pound) person to the top of a 30-meter (98-foot) tree in 30 seconds--safely. If the brakes fail, a backup brake kicks in to jam the wheels in place. As long as your tree isn't mushy and algae-covered (he tested those, too, and found the performance unsatisfactory), you're in business.

Here's more footage of the machine in action, including Bhat jumping up and down on it, to demonstrate that it safely stays in place:

Although he's been approached by several manufacturers, Bhat has turned them down, as he's not interested in profit. "I wish to partner with an organisation that would help me share the technology with the farmers to benefit them," he says. "I do not wish to seek royalties for such a venture. But I want to make sure that this product reaches as many farmers as possible, so that, in some way, it helps in the development of the overall agricultural scenario of the country."

Among the several treatments being proposed to fight Covid-19 are drugs used to attack parasites. One such candidate that has been much in the news is hydroxychloroquine.

ET takes a look at the vaccines that have moved from the pre-clinical to clinical phase of development for Covid-19, a step closer to finding a preventative drug against the deadly virus

Is a Fire Alarm System Too Loud? aconstanza Mon, 05/04/2020 - 12:29